https://www.psychiatrictimes.com/view/positive-phase-2-data-alixorexton-for-the-treatment-of-adults-with-narcolepsy-type-1?utm_source=www.psychiatrictimes.com&utm_medium=relatedContent
Positive phase 2 results show that treatment with alixorexton led to statistically significant and dose-dependent improvements in sleep latency among patients...
the treatmentpositivephasedataalixorexton